Home › Funds › GLENMEDE TRUST CO NA › JNJ

GLENMEDE TRUST CO NA position in JNJ

JOHNSON & JOHNSON · Health Care

GLENMEDE TRUST CO NA reported holding 1,428,293 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$264.8M, representing 1.29% of its reported portfolio and ranking #10 among its reported holdings. GLENMEDE TRUST CO NA has disclosed JNJ holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.43M sh
Reported value held$264.83M
Portfolio Weight1.29%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How GLENMEDE TRUST CO NA's JNJ position evolved

GLENMEDE TRUST CO NA first disclosed a stake in JNJ in Q3 2023 at 1,661,629 shares (US$258.8M). The position peaked in Q1 2026 at 1,422,668 shares, worth US$347.8M. Across 9 filings, GLENMEDE TRUST CO NA increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,428,293 shares valued at US$264.8M — an increase of 142,032 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.66M $258.80M New
Q4 2023 1.65M $258.98M Reduce
Q3 2024 1.66M $269.49M Add
Q4 2024 1.44M $207.72M Reduce
Q1 2025 1.42M $234.87M Reduce
Q4 2025 1.40M $290.42M Reduce
Q1 2026 1.42M $347.76M Add
Q2 2026 1.29M $326.67M Reduce
Q3 2026 1.43M $264.83M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$55.52B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has GLENMEDE TRUST CO NA held JNJ?

GLENMEDE TRUST CO NA has disclosed JNJ holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

What is GLENMEDE TRUST CO NA's current position in JNJ?

As of Q3 2026, GLENMEDE TRUST CO NA holds 1.43M shares of JNJ (JOHNSON & JOHNSON), valued at $264.83M, representing 1.29% of its reported portfolio and ranking #10.

Has GLENMEDE TRUST CO NA been buying or selling JNJ?

In the latest 13F filing (Q3 2026), GLENMEDE TRUST CO NA increased its position in JNJ. The position peaked in Q1 2026 at 1.42M shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.